Loading
NASDAQHealthcareMedical - Distribution
Latest quote
$0.1037
+$0.0008 · +0.78%
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Previous close
$0.1037
+$0.0008 · +0.78%
Pre-market
$0.10
−$0.0037 · -3.57%
Oct 8, 7:28 AM ET
Regular session · ET · Market data may be delayed.
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Day range
Current $0.1037
52-week range
Current $0.1037
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
65
Undervalued
Sentiment
51
Mixed
Risk
85
Extreme Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Day range
Current $0.1037
52-week range
Current $0.1037
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 13.43M USD | 20.31M USD | 16.69M USD | 12.56M USD |
| Cost of goods sold | 12.05M USD | 17.9M USD | 13.13M USD | 9.82M USD |
| Gross profit | 1.39M USD | 2.42M USD | 3.56M USD | 2.74M USD |
| Selling, general, and administrative | 2.4M USD | 2.22M USD | 1.89M USD | 1.76M USD |
| Operating expenses | 2.38M USD | 2.28M USD | 1.95M USD | 1.7M USD |
| Interest income | — | 1.74K USD | 474 USD | 219 USD |
| Interest expense | 133.4K USD | 97.67K USD | 82.77K USD | 23.24K USD |
| Depreciation and amortization | 687.12K USD | 1.07M USD | 925.58K USD | 714.59K USD |
| Operating income | −994.9K USD | 132.04K USD | 1.61M USD | 1.04M USD |
| Net income | −1.14M USD | −27.06K USD | 1.33M USD | 998.2K USD |
Company facts updated Oct 8, 2026.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
